192 related articles for article (PubMed ID: 9211494)
21. Insulin secretory capacity and the regulation of glucagon secretion in diabetic and non-diabetic alcoholic cirrhotic patients.
Kruszynska YT; Goulas S; Wollen N; McIntyre N
J Hepatol; 1998 Feb; 28(2):280-91. PubMed ID: 9514541
[TBL] [Abstract][Full Text] [Related]
22. Suppression of glucose production by GLP-1 independent of islet hormones: a novel extrapancreatic effect.
Prigeon RL; Quddusi S; Paty B; D'Alessio DA
Am J Physiol Endocrinol Metab; 2003 Oct; 285(4):E701-7. PubMed ID: 12773303
[TBL] [Abstract][Full Text] [Related]
23. Increased storage and secretion of islet amyloid polypeptide relative to insulin in the spontaneously diabetic GK rat.
Leckström A; Ostenson CG; Efendić S; Arnelo U; Permert J; Lundquist I; Westermark P
Pancreas; 1996 Oct; 13(3):259-67. PubMed ID: 8884847
[TBL] [Abstract][Full Text] [Related]
24. Dissociated secretion of islet amyloid polypeptide and insulin in serum-free culture media conditioned by human pancreatic adenocarcinoma cell lines.
Wang F; Larsson J; Abdiu A; Gasslander T; Westermark P; Adrian TE; Permert J
Int J Pancreatol; 1997 Apr; 21(2):157-64. PubMed ID: 9209957
[TBL] [Abstract][Full Text] [Related]
25. Islet amyloid polypeptide response to maximal hyperglycemia and arginine is altered in impaired glucose tolerance and type 2 diabetes mellitus.
Guardado-Mendoza R; Chávez AO; Jiménez-Ceja LM; Hansis-Diarte A; DeFronzo RA; Folli F; Tripathy D
Acta Diabetol; 2017 Jan; 54(1):53-61. PubMed ID: 27624579
[TBL] [Abstract][Full Text] [Related]
26. Islet amyloid polypeptide in Psammomys obesus (sand rat): effects of nutritionally induced diabetes and recovery on low-energy diet or vanadyl sulfate treatment.
Leckström A; Ziv E; Shafrir E; Westermark P
Pancreas; 1997 Nov; 15(4):358-66. PubMed ID: 9361089
[TBL] [Abstract][Full Text] [Related]
27. Pancreatic beta-cell function in cirrhotic patients with and without overt diabetes. C-peptide response to glucagon and to meal.
Marchesini G; Melli A; Checchia GA; Mattioli L; Capelli M; Cassarani S; Zoli M; Pisi E
Metabolism; 1985 Aug; 34(8):695-701. PubMed ID: 3894876
[TBL] [Abstract][Full Text] [Related]
28. Islet amyloid polypeptide tonally inhibits beta-, alpha-, and delta-cell secretion in isolated rat pancreatic islets.
Wang F; Adrian TE; Westermark GT; Ding X; Gasslander T; Permert J
Am J Physiol; 1999 Jan; 276(1):E19-24. PubMed ID: 9886946
[TBL] [Abstract][Full Text] [Related]
29. DPP-4 inhibition improves glucose tolerance and increases insulin and GLP-1 responses to gastric glucose in association with normalized islet topography in mice with beta-cell-specific overexpression of human islet amyloid polypeptide.
Ahrén B; Winzell MS; Wierup N; Sundler F; Burkey B; Hughes TE
Regul Pept; 2007 Oct; 143(1-3):97-103. PubMed ID: 17482289
[TBL] [Abstract][Full Text] [Related]
30. Banting lecture 1990. Beta-cells in type II diabetes mellitus.
Porte D
Diabetes; 1991 Feb; 40(2):166-80. PubMed ID: 1991568
[TBL] [Abstract][Full Text] [Related]
31. Distribution of pancreatic endocrine cells including IAPP-expressing cells in non-diabetic and type 2 diabetic cases.
Iki K; Pour PM
J Histochem Cytochem; 2007 Feb; 55(2):111-8. PubMed ID: 16982850
[TBL] [Abstract][Full Text] [Related]
32. Islet amyloid polypeptide: mechanisms of amyloidogenesis in the pancreatic islets and potential roles in diabetes mellitus.
Johnson KH; O'Brien TD; Betsholtz C; Westermark P
Lab Invest; 1992 May; 66(5):522-35. PubMed ID: 1573849
[TBL] [Abstract][Full Text] [Related]
33. Islet amyloid polypeptide and insulin expression are controlled differently in primary and transformed islet cells.
Madsen OD; Nielsen JH; Michelsen B; Westermark P; Betsholtz C; Nishi M; Steiner DF
Mol Endocrinol; 1991 Jan; 5(1):143-8. PubMed ID: 1850107
[TBL] [Abstract][Full Text] [Related]
34. Postprandial responses of incretin and pancreatic hormones in non-diabetic patients with end-stage renal disease.
Idorn T; Knop FK; Jørgensen M; Holst JJ; Hornum M; Feldt-Rasmussen B
Nephrol Dial Transplant; 2014 Jan; 29(1):119-27. PubMed ID: 24078334
[TBL] [Abstract][Full Text] [Related]
35. Effects of gastric inhibitory polypeptide, vasoactive intestinal polypeptide and peptide histidine isoleucine on the secretion of hormones by isolated mouse pancreatic islets.
Bailey CJ; Wilkes LC; Conlon JM; Armstrong PH; Buchanan KD
J Endocrinol; 1990 Jun; 125(3):375-9. PubMed ID: 1973701
[TBL] [Abstract][Full Text] [Related]
36. Plasma concentrations of islet amyloid polypeptide after glucagon administration in type 2 diabetic patients and non-diabetic subjects.
van Jaarsveld BC; Hackeng WH; Lips CJ; Erkelens DW
Diabet Med; 1993 May; 10(4):327-30. PubMed ID: 8508614
[TBL] [Abstract][Full Text] [Related]
37. Diabetes mellitus in pancreatic cancer: is it a causal relationship?
Katsumichi I; Pour PM
Am J Surg; 2007 Oct; 194(4 Suppl):S71-5. PubMed ID: 17903450
[TBL] [Abstract][Full Text] [Related]
38. Pancreatic islet response to diabetes during pregnancy in rats.
Gallego FQ; Sinzato YK; Miranda CA; Iessi IL; Dallaqua B; Volpato GT; Scarano WR; SanMartín S; Damasceno DC
Life Sci; 2018 Dec; 214():1-10. PubMed ID: 30366036
[TBL] [Abstract][Full Text] [Related]
39. The Expression of Aldolase B in Islets Is Negatively Associated With Insulin Secretion in Humans.
Gerst F; Jaghutriz BA; Staiger H; Schulte AM; Lorza-Gil E; Kaiser G; Panse M; Haug S; Heni M; Schütz M; Stadion M; Schürmann A; Marzetta F; Ibberson M; Sipos B; Fend F; Fleming T; Nawroth PP; Königsrainer A; Nadalin S; Wagner S; Peter A; Fritsche A; Richter D; Solimena M; Häring HU; Ullrich S; Wagner R
J Clin Endocrinol Metab; 2018 Dec; 103(12):4373-4383. PubMed ID: 30202879
[TBL] [Abstract][Full Text] [Related]
40. beta-cell glucokinase deficiency and hyperglycemia are associated with reduced islet amyloid deposition in a mouse model of type 2 diabetes.
Andrikopoulos S; Verchere CB; Terauchi Y; Kadowaki T; Kahn SE
Diabetes; 2000 Dec; 49(12):2056-62. PubMed ID: 11118007
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
